GLOBAL BONE MARROW TRANSPLANT MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

GLOBAL BONE MARROW TRANSPLANT MARKET 2019-2027

Market By Transplant Type, Indication, End-user, And Geography | Forecasts 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the global bone marrow transplant market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 5.13%. The market was assessed to be worth $11066.78 million in the year 2018 and is predicted to generate a revenue of approximately $17337.49 million by the year 2027. A bone marrow transplant is a process to replace damaged bone marrow with healthy stem cells. It is the fatty and soft tissue within the bones, functioning to produce the blood cells. Stem cells are also known as immature cells and are present in the bone marrow. It helps to increase various blood cells in the human body.

Bone marrow transplantation process is suggested to treat severe stages of Hodgkin and non-Hodgkin lymphomas, leukemia, aplastic and sickle cell anemia, multiple myeloma, thalassemia, etc. In the year 2015, globally more than 75,000 bone marrow transplants were performed, and the number is set to rise around 25% by the year 2020. Based on the bone marrow or stem cells source, the process of transplant is classified into conventional bone marrow transplant or peripheral stem cell transplant (PSCT). The rising advancement in the bone marrow transplant procedures and the constant researches and developments to minimize the risks and side effects is lifting the market significantly, aiming to offer improved care to the people across the globe.

Report scope can be customized per your requirements. Request For Customization

The ultimate option suggested by the doctors in critical cases of skin & bone cancer, fatal bone marrow disorder is bone marrow transplant. Therefore, it is concluded that the increasing prevalence of such fatal disorders is one of the major factor boosting the growth of the bone marrow transplant market globally. A disrupt in the functioning of the bone marrow can lead to major health issues in a human body. Moreover, unhealthy lifestyle, which involves excess alcohol or smoking addiction, unwholesome diets can also lead to the growing demand for major diseases in the body, which boost the market growth drastically.

Increase in the confidence of the patient towards the bone marrow procedure is known to be one of the prime trend witnessed in the market. This trend is attributed to the developing prognosis of the medical condition, backed by extensive research and development in bone marrow transplant. Hence, the overall bone marrow transplant market performance is expected to enhance as the advancement in the process keep getting less challenging and hi-tech. 

The bone marrow transplant market report from Triton discusses the key insights regarding the industry. In addition, the market attractiveness matrix, key buying criteria, Porter's five force analysis, and market trends are also studied in the report. 

The top market drivers such as the prevalence of cancer have increased worldwide, and increased federal funding are analyzed in detail in the report. Also, factors like the imbalance in the supply and demand for bone marrow transplant and ethical issues are restricting the market growth.

The key opportunities like technological inventions and reimbursement in the developed nations are expected to exhibit the growth of the market over the projected years. However, the high cost of treatment is challenging in the market growth, which is affecting the market demand negatively, especially in the emerging region.

The major geographies covered in the bone marrow transplant market are:

o    North America: the United States and Canada

o    Europe: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe

o    Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia Pacific

o    Latin America: Brazil, Mexico and Rest of Latin America

o    The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East and Africa

The bone marrow market is segmented into:

•    By transplant type:

o    Autologous bone marrow transplant

o    Allogeneic bone marrow transplant

•    By indication:

o    Multiple Myeloma

o    Acute Leukemia

o    Hodgkin Lymphoma

o    Non-Hodgkin Lymphoma

o    A solid tumor

o    Other indications

•    By end-users: 

o    Multispecialty clinics

o    Hospitals

o    Ambulatory Surgical Centers

The dominant companies involved in the bone marrow transplant market are Abbott Laboratories, Astellas Pharma Inc., Affymetrix Inc. (Acquired by Thermo Fisher), Diadexus Inc. (Acquired by Diazyme Laboratories), Stryker Corp., Illumina Inc., Agilent Technologies Inc., Qiagen N.V., SANOFI and Roche Diagnostics Ltd.

The strategic analysis for each of these companies in the bone marrow transplant market is covered in detail. The company market share helps to dive into the information about the key market players in this industry and their share in the market.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL BONE MARROW TRANSPLANT MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTERS FIVE FORCES OUTLOOK

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF RIVALRY

2.3. VENDOR SCORECARD

2.4. KEY BUYING CRITERIA

2.5. MARKET TRENDS

2.6. KEY INSIGHTS

2.7. MARKET ATTRACTIVENESS MATRIX

2.8. MARKET DRIVERS

2.8.1.   PREVALENCE OF CANCER HAS INCREASED WORLDWIDE

2.8.2.   INCREASE IN FEDERAL FUNDING OFFERINGS

2.9. MARKET RESTRAINTS

2.9.1.   IMBALANCE IN THE SUPPLY AND DEMAND FOR BONE MARROW TRANSPLANT

2.9.2.   ETHICAL ISSUES

2.10.            MARKET OPPORTUNITIES

2.10.1.                TECHNOLOGICAL INVENTIONS

2.10.2.                REIMBURSEMENT OPPORTUNITIES IN DEVELOPED NATIONS

2.11.            MARKET CHALLENGES

2.11.1.                HIGH COST OF TREATMENT

3.    BONE MARROW TRANSPLANT INDUSTRY OUTLOOK - BY TRANSPLANT TYPE

3.1. AUTOLOGOUS BONE MARROW TRANSPLANT

3.2. ALLOGENEIC BONE MARROW TRANSPLANT

4.    BONE MARROW TRANSPLANT INDUSTRY OUTLOOK - BY INDICATION

4.1. MULTIPLE MYELOMA

4.2. ACUTE LEUKEMIA

4.3. HODGKIN LYMPHOMA

4.4. NON-HODGKIN LYMPHOMA

4.5. SOLID TUMORS

4.6. OTHER INDICATION

5.    BONE MARROW TRANSPLANT INDUSTRY OUTLOOK - BY END-USER

5.1. MULTISPECIALTY CLINICS

5.2. HOSPITALS

5.3. AMBULATORY SURGICAL CENTERS

6.    BONE MARROW TRANSPLANT INDUSTRY – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   COUNTRY ANALYSIS

6.1.1.1.      UNITED STATES

6.1.1.2.      CANADA

6.2. EUROPE

6.2.1.   COUNTRY ANALYSIS

6.2.1.1.      THE UNITED KINGDOM (UK)

6.2.1.2.      FRANCE

6.2.1.3.      GERMANY

6.2.1.4.      SPAIN

6.2.1.5.      ITALY

6.2.1.6.      RUSSIA

6.2.1.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   COUNTRY ANALYSIS

6.3.1.1.      CHINA

6.3.1.2.      INDIA

6.3.1.3.      JAPAN

6.3.1.4.      SOUTH KOREA

6.3.1.5.      ASEAN COUNTRIES

6.3.1.6.      AUSTRALIA AND NEW ZEALAND

6.3.1.7.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   COUNTRY ANALYSIS

6.4.1.1.      BRAZIL

6.4.1.2.      MEXICO

6.4.1.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA (MEA)

6.5.1.   COUNTRY ANALYSIS

6.5.1.1.      SAUDI ARABIA

6.5.1.2.      TURKEY

6.5.1.3.      UNITED ARAB EMIRATES

6.5.1.4.      SOUTH AFRICA

6.5.1.5.      REST OF MIDDLE EAST AND AFRICA

7.    COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. AFFYMETRIX, INC. (ACQUIRED BY THERMOFISHER)

7.3. AGENDIA N.V.

7.4. AGILENT TECHNOLOGIES, INC.

7.5. AMBRILIA BIOPHARMA INC.

7.6. ASTELLAS PHARMA INC.

7.7. DIADEXUS INC. (ACQUIRED BY DIAZYME LABORATORIES)

7.8. ILLUMINA, INC.

7.9. QIAGEN N.V.

7.10.            ROCHE DIAGNOSTICS LTD

7.11.            SANOFI

7.12.            STRYKER CORPORATION

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        GLOBAL BONE MARROW TRANSPLANT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL BONE MARROW TRANSPLANT MARKET BY TRANSPLANT TYPE 2019-2027 ($ MILLION)

TABLE 3        GLOBAL BONE MARROW TRANSPLANT MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL BONE MARROW TRANSPLANT MARKET IN MULTIPLE MYELOMA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)

TABLE 5        GLOBAL BONE MARROW TRANSPLANT MARKET IN ACUTE LEUKEMIA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)

TABLE 6        GLOBAL BONE MARROW TRANSPLANT MARKET IN HODGKIN LYMPHOMA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)

TABLE 7        GLOBAL BONE MARROW TRANSPLANT MARKET IN NON-HODGKIN LYMPHOMA BY TRANSPLANT TYPE 2019-2027 ($ MILLION)

TABLE 8        GLOBAL BONE MARROW TRANSPLANT MARKET IN SOLID TUMORS BY TRANSPLANT TYPE 2019-2027 ($ MILLION)

TABLE 9        GLOBAL BONE MARROW TRANSPLANT MARKET, BY REGION 2019-2027($ MILLION)

TABLE 10      NORTH AMERICA BONE MARROW TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 11      EUROPE BONE MARROW TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 12      ASIA-PACIFIC BONE MARROW TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 13      LATIN AMERICA BONE MARROW TRANSPLANT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 14      MIDDLE EAST AND AFRICA BONE MARROW TRANSPLANT MARKET 2019-2027 BY COUNTRY ($ MILLION)

List of Figures

FIGURE 1      BONE MARROW BLOOD COMPONENTS

FIGURE 2      GLOBAL BONE MARROW MARKET TRANSPLANT 2019-2027 ($ MILLION)

FIGURE 3      DIFFERENT TYPES OF CANCERS MANAGED BY BONE MARROW TRANSPLANT

FIGURE 4      ETHICAL ISSUES REQUIREMENTS IN BONE MARROW TRANSPLANT

FIGURE 5      PHASES IN BONE MARROW TRANSPLANT

FIGURE 6      GLOBAL BONE MARROW TRANSPLANT MARKET IN AUTOLOGOUS BONE MARROW TRANSPLANT 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL BONE MARROW TRANSPLANT MARKET IN ALLOGENIC BONE MARROW TRANSPLANT 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL BONE MARROW TRANSPLANT MARKET IN MULTIPLE MYELOMA 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL BONE MARROW TRANSPLANT MARKET IN ACUTE LEUKEMIA 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL BONE MARROW TRANSPLANT MARKET IN HODGKIN LYMPHOMA 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL BONE MARROW TRANSPLANT MARKET IN NON-HODGKIN LYMPHOMA 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL BONE MARROW TRANSPLANT MARKET IN SOLID TUMORS 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL BONE MARROW TRANSPLANT MARKET IN OTHER INDICATION 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL BONE MARROW TRANSPLANT MARKET IN MULTISPECIALTY CLINICS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL BONE MARROW TRANSPLANT MARKET IN HOSPITALS 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL BONE MARROW TRANSPLANT MARKET IN AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)

FIGURE 17   UNITED STATES BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 18   CANADA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 19   PERCENTAGE VISE DISTRIBUTION OF VARIOUS CANCERS ENGLAND (2016)

FIGURE 20   THE UNITED KINGDOM BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 21   FRANCE BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 22   GERMANY BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 23   SPAIN BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 24   ITALY BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 25   RUSSIA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 26   REST OF EUROPE BONE MARROW TRANSPLANT  MARKET 2019-2027 ($ MILLION)

FIGURE 27   CHINA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 28   INDIA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 29   JAPAN BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 30   SOUTH KOREA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 31   ASEAN COUNTRIES BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE  32  AUSTRALIA AND NEW ZEALAND BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 33   REST OF ASIA-PACIFIC BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 34   BRAZIL BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 35   MEXICO BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 36   REST OF LATIN AMERICA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 37   SAUDI ARABIA AMERICA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 38   TURKEY BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 39   UNITED ARAB EMIRATES BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 40   SOUTH AFRICA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

FIGURE 41   REST OF MIDDLE EAST AND AFRICA BONE MARROW TRANSPLANT MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;